Galapagos

EuroBiotech: More Articles of Note

Galapagos, Gilead include high dose in PhIII RA trial after talk with FDA

AbbVie adds $250M in milestones to Galapagos cystic fibrosis deal

EuroBiotech Report: Galapagos bolsters case for Gilead-partnered Crohn’s drug

Galapagos bolsters case for Gilead-partnered Crohn’s drug with 20-week data